Similar articles for PMID: 28476781

Year	Number of Results
1997	1
1998	2
2001	1
2002	2
2003	3
2005	1
2006	4
2007	8
2008	4
2009	9
2010	8
2011	11
2012	14
2013	26
2014	26
2015	26
2016	32
2017	35
2018	38
2019	31
2020	36
2021	37
2022	18
2023	12
2024	0

1

Updates and Critical Evaluation on Novel Biomarkers for the Malignant Progression of Intraductal Papillary Mucinous Neoplasms of the Pancreas.

Moris D, Damaskos C, Spartalis E, Papalampros A, Vernadakis S, Dimitroulis D, Griniatsos J, Felekouras E, Nikiteas N. Moris D, et al. Anticancer Res. 2017 May;37(5):2185-2194. doi: 10.21873/anticanres.11553. Anticancer Res. 2017. PMID: 28476781 Review.

2

Value of adding GNAS testing to pancreatic cyst fluid KRAS and carcinoembryonic antigen analysis for the diagnosis of intraductal papillary mucinous neoplasms.

Kadayifci A, Atar M, Wang JL, Forcione DG, Casey BW, Pitman MB, Brugge WR. Kadayifci A, et al. Dig Endosc. 2017 Jan;29(1):111-117. doi: 10.1111/den.12710. Epub 2016 Oct 4. Dig Endosc. 2017. PMID: 27514845

3

Preoperative GNAS and KRAS testing in the diagnosis of pancreatic mucinous cysts.

Singhi AD, Nikiforova MN, Fasanella KE, McGrath KM, Pai RK, Ohori NP, Bartholow TL, Brand RE, Chennat JS, Lu X, Papachristou GI, Slivka A, Zeh HJ, Zureikat AH, Lee KK, Tsung A, Mantha GS, Khalid A. Singhi AD, et al. Clin Cancer Res. 2014 Aug 15;20(16):4381-9. doi: 10.1158/1078-0432.CCR-14-0513. Epub 2014 Jun 17. Clin Cancer Res. 2014. PMID: 24938521

4

Clinical implication of serum carcinoembryonic antigen and carbohydrate antigen 19-9 for the prediction of malignancy in intraductal papillary mucinous neoplasm of pancreas.

Kim JR, Jang JY, Kang MJ, Park T, Lee SY, Jung W, Chang J, Shin Y, Han Y, Kim SW. Kim JR, et al. J Hepatobiliary Pancreat Sci. 2015 Sep;22(9):699-707. doi: 10.1002/jhbp.275. Epub 2015 Jul 14. J Hepatobiliary Pancreat Sci. 2015. PMID: 26178866

5

Distinction of Invasive Carcinoma Derived From Intraductal Papillary Mucinous Neoplasms From Concomitant Ductal Adenocarcinoma of the Pancreas Using Molecular Biomarkers.

Tamura K, Ohtsuka T, Date K, Fujimoto T, Matsunaga T, Kimura H, Watanabe Y, Miyazaki T, Ohuchida K, Takahata S, Ishigami K, Oda Y, Mizumoto K, Nakamura M, Tanaka M. Tamura K, et al. Pancreas. 2016 Jul;45(6):826-35. doi: 10.1097/MPA.0000000000000563. Pancreas. 2016. PMID: 26646266

6

MUC2 expression and prevalence of high-grade dysplasia and invasive carcinoma in mixed-type intraductal papillary mucinous neoplasm of the pancreas.

Masuda A, Arisaka Y, Hara S, Matsumoto I, Takenaka M, Sakai A, Shiomi H, Matsuki N, Sugimoto M, Fujita T, Hayakumo T, Ku Y, Ogino S, Azuma T, Kutsumi H. Masuda A, et al. Pancreatology. 2013 Nov-Dec;13(6):583-8. doi: 10.1016/j.pan.2013.08.007. Epub 2013 Aug 30. Pancreatology. 2013. PMID: 24280573

7

Plasma MicroRNAs as Novel Biomarkers for Patients with Intraductal Papillary Mucinous Neoplasms of the Pancreas.

Permuth-Wey J, Chen DT, Fulp WJ, Yoder SJ, Zhang Y, Georgeades C, Husain K, Centeno BA, Magliocco AM, Coppola D, Malafa M. Permuth-Wey J, et al. Cancer Prev Res (Phila). 2015 Sep;8(9):826-34. doi: 10.1158/1940-6207.CAPR-15-0094. Cancer Prev Res (Phila). 2015. PMID: 26314797 Free PMC article.

8

The discrete nature and distinguishing molecular features of pancreatic intraductal tubulopapillary neoplasms and intraductal papillary mucinous neoplasms of the gastric type, pyloric gland variant.

Yamaguchi H, Kuboki Y, Hatori T, Yamamoto M, Shimizu K, Shiratori K, Shibata N, Shimizu M, Furukawa T. Yamaguchi H, et al. J Pathol. 2013 Nov;231(3):335-41. doi: 10.1002/path.4242. J Pathol. 2013. PMID: 23893889

9

Impact of next-generation sequencing on the clinical diagnosis of pancreatic cysts.

Jones M, Zheng Z, Wang J, Dudley J, Albanese E, Kadayifci A, Dias-Santagata D, Le L, Brugge WR, Fernandez-del Castillo C, Mino-Kenudson M, Iafrate AJ, Pitman MB. Jones M, et al. Gastrointest Endosc. 2016 Jan;83(1):140-8. doi: 10.1016/j.gie.2015.06.047. Epub 2015 Aug 5. Gastrointest Endosc. 2016. PMID: 26253016

10

Intraductal papillary mucinous neoplasms of the pancreas: performance of pancreatic fluid analysis for positive diagnosis and the prediction of malignancy.

Maire F, Voitot H, Aubert A, Palazzo L, O'Toole D, Couvelard A, Levy P, Vidaud M, Sauvanet A, Ruszniewski P, Hammel P. Maire F, et al. Am J Gastroenterol. 2008 Nov;103(11):2871-7. doi: 10.1111/j.1572-0241.2008.02114.x. Epub 2008 Sep 4. Am J Gastroenterol. 2008. PMID: 18775021

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

331 results

Results by year